Literature DB >> 24955498

The effects of the C-terminal amidation of mastoparans on their biological actions and interactions with membrane-mimetic systems.

Alessandra V R da Silva1, Bibiana M De Souza1, Marcia P Dos Santos Cabrera2, Nathalia B Dias1, Paulo C Gomes1, João Ruggiero Neto3, Rodrigo G Stabeli4, Mario S Palma5.   

Abstract

Polycationic peptides may present their C-termini in either amidated or acidic form; however, the effects of these conformations on the mechanisms of interaction with the membranes in general were not properly investigated up to now. Protonectarina-MP mastoparan with an either amidated or acidic C-terminus was utilized to study their interactions with anionic and zwitterionic vesicles, using measurements of dye leakage and a combination of H/D exchange and mass spectrometry to monitor peptide-membrane interactions. Mast cell degranulation, hemolysis and antibiosis assays were also performed using these peptides, and the results were correlated with the structural properties of the peptides. The C-terminal amidation promotes the stabilization of the secondary structure of the peptide, with a relatively high content of helical conformations, permitting a deeper interaction with the phospholipid constituents of animal and bacterial cell membranes. The results suggested that at low concentrations Protonectarina-MP interacts with the membranes in a way that both terminal regions remain positioned outside the external surface of the membrane, while the α-carbon backbone becomes partially embedded in the membrane core and changing constantly the conformation, and causing membrane destabilization. The amidation of the C-terminal residue appears to be responsible for the stabilization of the peptide conformation in a secondary structure that is richer in α-helix content than its acidic congener. The helical, amphipathic conformation, in turn, allows a deeper peptide-membrane interaction, favoring both biological activities that depend on peptide structure recognition by the GPCRs (such as exocytosis) and those activities dependent on membrane perturbation (such as hemolysis and antibiosis).
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antimicrobial peptide; H/D exchange; Mass spectrometry; Mastoparan; Peptide–membrane interaction; Peptidomics

Mesh:

Substances:

Year:  2014        PMID: 24955498     DOI: 10.1016/j.bbamem.2014.06.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  18 in total

1.  Posttranslational modifications of α-conotoxins: sulfotyrosine and C-terminal amidation stabilise structures and increase acetylcholine receptor binding.

Authors:  Thao N T Ho; Han Siean Lee; Shilpa Swaminathan; Lewis Goodwin; Nishant Rai; Brianna Ushay; Richard J Lewis; K Johan Rosengren; Anne C Conibear
Journal:  RSC Med Chem       Date:  2021-07-26

2.  Mastoparan is a membranolytic anti-cancer peptide that works synergistically with gemcitabine in a mouse model of mammary carcinoma.

Authors:  Ashley L Hilchie; Andrew J Sharon; Evan F Haney; David W Hoskin; Marcel B Bally; Octavio L Franco; Jennifer A Corcoran; Robert E W Hancock
Journal:  Biochim Biophys Acta       Date:  2016-10-18

Review 3.  Lipid-packing perturbation of model membranes by pH-responsive antimicrobial peptides.

Authors:  Dayane S Alvares; Taisa Giordano Viegas; João Ruggiero Neto
Journal:  Biophys Rev       Date:  2017-08-29

4.  What Makes a Good Pore Former: A Study of Synthetic Melittin Derivatives.

Authors:  Aliasghar Sepehri; Leo PeBenito; Almudena Pino-Angeles; Themis Lazaridis
Journal:  Biophys J       Date:  2020-03-03       Impact factor: 4.033

5.  Improving the Gastrointestinal Stability of Linaclotide.

Authors:  Nayara Braga Emidio; Hue N T Tran; Asa Andersson; Philip E Dawson; Fernando Albericio; Irina Vetter; Markus Muttenthaler
Journal:  J Med Chem       Date:  2021-05-12       Impact factor: 7.446

Review 6.  Pharmacological Alternatives for the Treatment of Neurodegenerative Disorders: Wasp and Bee Venoms and Their Components as New Neuroactive Tools.

Authors:  Juliana Silva; Victoria Monge-Fuentes; Flávia Gomes; Kamila Lopes; Lilian dos Anjos; Gabriel Campos; Claudia Arenas; Andréia Biolchi; Jacqueline Gonçalves; Priscilla Galante; Leandro Campos; Márcia Mortari
Journal:  Toxins (Basel)       Date:  2015-08-18       Impact factor: 4.546

7.  Peptidoglycan potentiates the membrane disrupting effect of the carboxyamidated form of DMS-DA6, a Gram-positive selective antimicrobial peptide isolated from Pachymedusa dacnicolor skin.

Authors:  Sébastien Cardon; Emmanuelle Sachon; Ludovic Carlier; Thierry Drujon; Astrid Walrant; Estefanía Alemán-Navarro; Verónica Martínez-Osorio; Dominique Guianvarc'h; Sandrine Sagan; Yannick Fleury; Rodrigue Marquant; Christophe Piesse; Yvonne Rosenstein; Constance Auvynet; Claire Lacombe
Journal:  PLoS One       Date:  2018-10-16       Impact factor: 3.240

8.  Development of a novel RANKL-based peptide, microglial healing peptide1-AcN (MHP1-AcN), for treatment of ischemic stroke.

Authors:  Munehisa Shimamura; Hironori Nakagami; Hideo Shimizu; Hideyuki Mukai; Ryosuke Watanabe; Takeshi Okuzono; Tomohiro Kawano; Yuka Ikeda; Hiroki Hayashi; Shota Yoshida; Nan Ju; Hideki Mochizuki; Ryuichi Morishita
Journal:  Sci Rep       Date:  2018-12-11       Impact factor: 4.379

Review 9.  Strategies towards Targeting Gαi/s Proteins: Scanning of Protein-Protein Interaction Sites To Overcome Inaccessibility.

Authors:  Britta Nubbemeyer; Anna Pepanian; Ajay Abisheck Paul George; Diana Imhof
Journal:  ChemMedChem       Date:  2021-03-22       Impact factor: 3.466

10.  Evaluation of the bioactivity of a mastoparan peptide from wasp venom and of its analogues designed through targeted engineering.

Authors:  Xiaoling Chen; Luyao Zhang; Yue Wu; Lei Wang; Chengbang Ma; Xinping Xi; Olaf R P Bininda-Emonds; Chris Shaw; Tianbao Chen; Mei Zhou
Journal:  Int J Biol Sci       Date:  2018-04-25       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.